학술논문

Encorafenib and binimetinib followed by radiotherapy for patients with symptomatic BRAF mutated melanoma brain metastases: GEM1802/E-BRAIN clinical trial
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2022, 33 7, pS926-pS926, 1p. Supplement: 7
Subject
Language
English
ISSN
15698041